Eduardo Aliprandini

Paris, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Late killing of Plasmodium berghei sporozoites in the liver by an anti-circumsporozoite protein antibody.

Late killing of Plasmodium berghei sporozoites in the liver by an anti-circumsporozoite protein antibody.

Journal: eLife
Published: February 14, 2025

Killing of Plasmodium Sporozoites by Basic Amphipathic α-Helical Fusion Peptides.

Killing of Plasmodium Sporozoites by Basic Amphipathic α-Helical Fusion Peptides.

Journal: Microorganisms
Published: January 31, 2024

The Anopheles leucine-rich repeat protein APL1C is a pathogen binding factor recognizing Plasmodium ookinetes and sporozoites.

The Anopheles leucine-rich repeat protein APL1C is a pathogen binding factor recognizing Plasmodium ookinetes and sporozoites.

Journal: PLoS pathogens
Published: September 03, 2023

Cytotoxicity of human antibodies targeting the circumsporozoite protein is amplified by 3D substrate and correlates with protection.

Cytotoxicity of human antibodies targeting the circumsporozoite protein is amplified by 3D substrate and correlates with protection.

Journal: Cell reports
Published: December 20, 2022

Expanding the Malaria Antibody Toolkit: Development and Characterisation of Plasmodium falciparum RH5, CyRPA, and CSP Recombinant Human Monoclonal Antibodies.

Expanding the Malaria Antibody Toolkit: Development and Characterisation of Plasmodium falciparum RH5, CyRPA, and CSP Recombinant Human Monoclonal Antibodies.

Journal: Frontiers in cellular and infection microbiology
Published: March 21, 2022

A Multistage Formulation Based on Full-Length CSP and AMA-1 Ectodomain of Plasmodium vivax Induces High Antibody Titers and T-cells and Partially Protects Mice Challenged with a Transgenic Plasmodium berghei Parasite.

A Multistage Formulation Based on Full-Length CSP and AMA-1 Ectodomain of Plasmodium vivax Induces High Antibody Titers and T-cells and Partially Protects Mice Challenged with a Transgenic Plasmodium berghei Parasite.

Journal: Microorganisms
Published: May 20, 2020

Protective Malaria Vaccine in Mice Based on the Plasmodium vivax Circumsporozoite Protein Fused with the Mumps Nucleocapsid Protein.

Protective Malaria Vaccine in Mice Based on the Plasmodium vivax Circumsporozoite Protein Fused with the Mumps Nucleocapsid Protein.

Journal: Vaccines
Published: March 30, 2020

Recombinant measles vaccine expressing malaria antigens induces long-term memory and protection in mice.

Recombinant measles vaccine expressing malaria antigens induces long-term memory and protection in mice.

Journal: NPJ vaccines
Published: June 27, 2018

Cytotoxic anti-circumsporozoite antibodies target malaria sporozoites in the host skin.

Cytotoxic anti-circumsporozoite antibodies target malaria sporozoites in the host skin.

Journal: Nature microbiology
Published: September 25, 2017
Showing 1-9 of 9

Last Updated: 09/26/2026